Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 31;15(1):69.
doi: 10.1186/s12916-017-0837-1.

The 2016 classification criteria for primary Sjogren's syndrome: what's new?

Franco Franceschini  1 , Ilaria Cavazzana  2 , Laura Andreoli  1   3 , Angela Tincani  1   3
Affiliations

The 2016 classification criteria for primary Sjogren's syndrome: what's new?

Franco Franceschini et al. BMC Med. .

Abstract

New 2016 ACR/EULAR classification criteria for primary Sjogren's syndrome (SS) have been developed and endorsed by the ACR. The newly proposed criteria include simple-to-perform items.Two important points of the new criteria should be considered. Firstly, they indicate that either salivary gland biopsy or anti-Ro must be positive in order to corroborate the inflammatory and autoimmune nature of the disease. Secondly, the criteria recognize the systemic nature of SS, namely that patients without salivary or ocular glandular symptoms, but with extraglandular manifestations and B cell activation markers were also included in the SS classification. Additionally, the new criteria modified some technical points. The ocular staining score threshold was increased to 5 due to the higher specificity. The immunological profile includes only anti-Ro antibodies, while positivity for antinuclear antibodies and rheumatoid factor or isolated anti-La was excluded due to a lack of specificity.The 2016 ACR/EULAR criteria are suitable for early identification of SS, providing patients with the opportunity of enrollment in clinical trials for new specific treatment. Although validation has been successful, the real life application of these criteria will test their performance.

Keywords: ACR; Anti-La/SSB; Anti-Ro/SSA; Classification criteria; EULAR; Extra-glandular features; Ocular staining score; Sjogren’s syndrome.

PubMed Disclaimer

References

    1. Tincani A, Andreoli L, Cavazzana I, et al. Novel aspects Sjogren’s syndrome in 2012. BMC Med. 2013;11:93. doi: 10.1186/1741-7015-11-93. - DOI - PMC - PubMed
    1. Ramos-Casals M, Brito-Zeron P, Solans R, et al. Systemic involvement in primary Sjogren’s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry) Rheumatology (Oxford) 2014;53:321–31. doi: 10.1093/rheumatology/ket349. - DOI - PubMed
    1. Franceschini F, Cavazzana I. Anti-Ro/SSA and anti-La/SSB antibodies. Autoimmunity. 2005;38:55–63. doi: 10.1080/08916930400022954. - DOI - PubMed
    1. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjogren’s syndrome: a clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore) 1965;44:187–231. doi: 10.1097/00005792-196505000-00001. - DOI - PubMed
    1. Daniels TE, Silverman S, Jr, Michalski JP, Greenspan JS, Sylvester RA, Talal N. The oral component of Sjogren’s syndrome. Oral Surg Oral Med Oral Pathol. 1975;39:875–85. doi: 10.1016/0030-4220(75)90108-5. - DOI - PubMed